medigraphic.com
ISSN 1729-6935 (Electronic)
16 de abril

2020, Number 278

<< Back Next >>

16 de abril 2020; 59 (278)

Clinical and prognostic factors in patients with diabetes mellitus infected by SARS-CoV-2. A review

Zapata MJA, Gallegos-Pérez IA, Zapata MCI

Language: Spanish
References: 27
Page: 1-5
PDF size: 245.01 Kb.


ABSTRACT

Introduction: the coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus type 2, is a major public health problem so far in the 21st century. In this disease, prevention is essential in risk groups such as patients with diabetes mellitus, a condition of interest in the medical area due to its association with an unfavorable prognosis of disease after infection with SARS-CoV-2. Objective: to describe evidence of the link between diabetes mellitus, modifiable and non-modifiable clinical factors in these patients and their relationship with the prognosis after infection with SARS-CoV-2. Material and methods: a bibliographic search was carried out in the databases: PubMed, ScienceDirect and Scopus. The search was restricted to the terms “coronavirus”, “COVID-19”, “diabetes mellitus” and “prognosis” for Spanish and English. Retrospective cohort primary studies were selected. Development: diabetes mellitus is associated with an unfavorable prognosis of disease after infection with SARS-CoV-2. An inadequate glycemic control and body mass index, together with a longer time of diabetes mellitus progression and patient age, are markers of a poorer disease prognosis after COVID-19 in diabetic patients. Conclusions: it is useful to know the relationship between clinical factors in patients with diabetes mellitus and its association with the prognosis of disease after infection with SARS-CoV-2. This makes it possible to stratify, predict and optimize preventive treatment in patients with this condition.


REFERENCES

  1. Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents [Internet] 2020 [citado 20 septiembre 2020]; 56 (2): 106054. Disponible en: https://www.sciencedirect.com/science/article/pii/S0924857920302247?via%3Dihub

  2. Reporte epidemiológico semanal de la enfermedad por coronavirus 2019 (COVID-19), Organización Mundial de la Salud. 13 de septiembre 2020. [Internet] 2020 [citado 20 septiembre 2020]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200914-weekly-epi-update-5.pdf?sfvrsn=cf929d04_2

  3. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin [Internet] 2019 [citado 20 septiembre 2020]; 157: 107843. Disponible en: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(19)31230-6/fulltext

  4. Documento MINSAP. Anuario Estadístico de Salud 48 edición. Registro oficial de gobierno Ministerio de Salud Pública de Cuba. [Internet] 2020 [citado 20 septiembre 2020]. Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020.pdf

  5. Ministerio de Salud de Chile. Encuesta Nacional de Salud 2016-2017. Primeros resultados. Santiago de Chile: MINSAL. [Internet] 2017 [citado 20 septiembre 2020]. Disponible en: https://www.minsal.cl/wp-content/uploads/2017/11/ENS-2016-17_PRIMEROS-RESULTADOS.pdf

  6. Diagnosis and Classification of Diabetes Meliitus. Diabetes Care [Internet] 2004 [citado 20 de septiembre de 2020]; 27 (Supplement 1): S5-S10. Disponible en: https://care.diabetesjournals.org/content/27/suppl_1/s5

  7. Corral A, Pría MC, Seuc H. Desigualdades en la carga global de enfermedad según condiciones de vida. Cuba 2013-2015. Horiz sanitario [Internet] 2019 [citado 18 septiembre 2020]; 18 (3): 337-346. Disponible en: https://doi.org/10.19136/hs.a18n3.3194

  8. Sapunar J. Epidemiología de la Diabetes Mellitus en Chile. Rev méd Clín Las Condes [Internet] 2016 [citado 20 septiembre 2020]; 27 (2): 146-151. Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-epidemiologia-de-la-diabetes-mellitus-S0716864016300037

  9. Sandooja R, Vura NVRK, Morocco M. Heightened ACE Activity and Unfavorable Consequences in COVID-19 Diabetic Subjects. Int J Endocrinol [Internet] 2020 [citado 20 septiembre 2020]; 2020: 1-5. Disponible en: https://www.hindawi.com/journals/ije/2020/7847526/

  10. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med [Internet] 2020 [citado 20 septiembre 2020]; 180 (7): 934. Disponible en: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2763184

  11. Tikellis C, Thomas MC. Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. Int J Pept [Internet] 2012 [citado 20 septiembre 2020]; 2012:1-8. Disponible en: https://www.hindawi.com/journals/ijpep/2012/256294/

  12. Lumbers ER, Delforce SJ, Pringle KG, Smith GR. The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials. Front Med [Internet] 2020 [citado 20 septiembre 2020]; 7: 248. Disponible en: https://www.frontiersin.org/articles/10.3389/fmed.2020.00248/full

  13. Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, et al. Association of diabetes mellitus with disease severity and prognosis in COVID-19: A retrospective cohort study. Diabetes Res Clin Pract [Internet] 2020 [citado 20 septiembre 2020]; 165: 108227. Disponible en: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(20)30477-0/fulltext

  14. Liu Z, Li J, Huang J, Guo L, Gao R, Luo K, et al. Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, Wuhan. Front Endocrinol [Internet] 2020 [citado 20 de septiembre 2020]; 11:478. Disponible en: https://www.frontiersin.org/articles/10.3389/fendo.2020.00478/full

  15. Barron E, Bakhai C, Kar P, Weaver A, Bradley D, Ismail H, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endo [Internet] 2020 [citado 20 de septiembre 2020]; 8 (10): 813-22. Disponible en: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30272-2/fulltext

  16. Zhu L, She Z, Cheng X, Qin J, Zhang X, Cai J, et al. Association of Blood Glucose Control and Outcomes in Patients with beting Mortality Zonet] 2012 [citado 20 septiembre 2020]; 2012:1-8. Disponible en: https://www.hindawi.com/journals/ijpep/2012/256294/

  17. Chung SM, Lee YY, Ha E, Yoon JS, Won KC, Lee HW, et al. The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study. Diabetes Metab [Internet] 2020 [citado 20 de septiembre 2020]; 44 (3): 405. Disponible en: https://e-dmj.org/DOIx.php?id=10.4093/dmj.2020.0105

  18. Holman N, Knighton P, Kar P, O’Keefe J, Curley M, Weaver A, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol [Internet] 2020 [citado 20 de septiembre 2020]; 8 (19): 823-33. Disponible en: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30271-0/fulltext

  19. Glycemic Targets: Standards of Medical Care in Diabetes—2020. Diabetes Care [Internet] 2020 [citado 20 de septiembre 2020]; 43 (Supplement 1): S66-S76. Disponible en: https://care.diabetesjournals.org/content/43/Supplement_1/S66

  20. Older Adults: Standards of Medical Care in Diabetes—2020. Diabetes Care [Internet] 2020 [citado 20 de septiembre 2020]; 43 (Supplement 1): S152-S162. Disponible en: https://care.diabetesjournals.org/content/43/Supplement_1/S152

  21. Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Correction to: Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia [Internet] 2020 [citado 20 de septiembre 2020]; 63 (9): 1953-7. Disponible en: https://link.springer.com/article/10.1007%2Fs00125-020-05180-x

  22. Xu Z, Wang Z, Wang S, Ye Y, Luo D, Wan L, et al. The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID ‐19. J Diabetes [Internet] 2020 [citado 20 de septiembre 2020]; [Early View]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/1753-0407.13084

  23. Zhang J, Kong W, Xia P, Xu Y, Li L, Li Q, et al. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019. Front Endocrinol [Internet] 2020 [citado 20 de septiembre 2020]; 11: 525 Disponible en: https://www.frontiersin.org/articles/10.3389/fendo.2020.00525/full

  24. Coppelli A, Giannarelli R, Aragona M, Penno G, Falcone M, Tiseo G, et al. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study. Diabetes Care [Internet] 2020 [citado 20 de septiembre 2020]; dc201380. Disponible en: https://care.diabetesjournals.org/content/early/2020/08/07/dc20-1380

  25. Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol [Internet] 2020 [citado 20 de septiembre 2020]; 8 (6): 546-50. Disponible en: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(20)30152-2/fulltext

  26. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab [Internet] 2020 [citado 20 de septiembre 2020]; 105 (8): 2752-61. Disponible en: https://academic.oup.com/jcem/article/105/8/2752/5849337

  27. Kim MK, Jeon J, Kim S, Moon JS, Cho NH, Han E, et al. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea. Diabetes Metab [Internet] 2020 [citado 20 de septiembre 2020]; 44 (4): 602. Disponible en: https://e-dmj.org/DOIx.php?id=10.4093/dmj.2020.0146




2020     |     www.medigraphic.com